STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marianne Muhlebach, MD
University of North Carolina, Chapel Hill
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- National Jewish Health
Denver, Colorado, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- St. Louis Children'S Hospital
St Louis, Missouri, United States
- N.C. Memorial Hospital and N.C. Children'S Hospital
Chapel Hill, North Carolina, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Texas Children'S Hospital, Baylor College of Medicine
Houston, Texas, United States
- University of Washington Medical Center and Seattle Children'S
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Apr 2018
- Primary completion
- 30 Sept 2025
- Completion
- 31 Jan 2026
- Last update posted
- 17 Feb 2026
- Registered enrollment
- 37
- Registry id
- NCT03489629
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.